Clinical Perinatal Software

Global Clinical Perinatal Software Market to Reach US$480.5 Million by 2030

The global market for Clinical Perinatal Software estimated at US$296.8 Million in the year 2024, is expected to reach US$480.5 Million by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Integrated Clinical Perinatal Software, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$295.3 Million by the end of the analysis period. Growth in the Standalone Clinical Perinatal Software segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$80.9 Million While China is Forecast to Grow at 13.3% CAGR

The Clinical Perinatal Software market in the U.S. is estimated at US$80.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$105.4 Million by the year 2030 trailing a CAGR of 13.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Clinical Perinatal Software Market – Key Trends & Drivers Summarized

Why Is Clinical Perinatal Software Becoming Essential in Modern Maternity and Neonatal Care?

Clinical perinatal software has become a critical tool in enhancing the quality, safety, and efficiency of care during the most delicate stages of life—pregnancy, labor, delivery, and the immediate postnatal period. As maternal and neonatal health outcomes gain global attention, healthcare providers are increasingly adopting digital solutions that allow for real-time monitoring, risk assessment, and evidence-based decision-making. Clinical perinatal software offers integrated solutions for fetal monitoring, electronic documentation, labor progression analysis, and neonatal assessments, supporting clinicians in tracking vital parameters and intervening proactively in high-risk cases. With rising maternal age, higher incidence of pregnancy complications, and increasing cesarean rates, hospitals are relying more on perinatal software to ensure consistent care standards, reduce errors, and manage clinical workflows efficiently. Moreover, the ability to centralize maternal and fetal data, integrate it into electronic health records (EHRs), and provide automated alerts enhances both care coordination and clinical outcomes. These systems are becoming indispensable not just for obstetricians and midwives but also for hospital administrators focused on improving maternal care quality metrics and regulatory compliance.

How Are Technological Advancements and Integration Capabilities Transforming Perinatal Systems?

The clinical perinatal software market is being rapidly reshaped by advancements in interoperability, analytics, and user-centric technology features. Modern systems offer robust integration with EHRs, radiology information systems (RIS), and laboratory information systems (LIS), ensuring a comprehensive and cohesive patient data ecosystem. Advanced features such as real-time fetal heart rate interpretation, labor progression tracking, maternal vital sign monitoring, and AI-assisted clinical decision support are enhancing care precision. Innovations like remote monitoring tools and wireless fetal sensors are enabling enhanced mobility and comfort for patients, while ensuring continuous data capture and clinician oversight. Software platforms are also incorporating predictive analytics and machine learning algorithms to detect patterns indicative of complications such as fetal distress, preeclampsia, or preterm labor. Cloud-based deployment models, mobile accessibility, and customizable dashboards are improving data accessibility and communication among multidisciplinary teams. Furthermore, built-in compliance tools ensure that documentation aligns with international standards and facilitates medico-legal audit trails. These technological advancements are transforming clinical perinatal software into a dynamic, real-time support system for critical care scenarios.

What Role Do Institutional Demand, Policy Mandates, and Demographic Trends Play in Shaping Market Growth?

Institutional demand, evolving policy frameworks, and demographic shifts are major forces influencing the adoption of clinical perinatal software globally. Healthcare institutions—particularly maternity hospitals, neonatal intensive care units (NICUs), and birthing centers—are prioritizing digital transformation initiatives to improve care quality and patient safety. Government mandates for maternal health improvement, accreditation requirements, and national quality programs are encouraging hospitals to adopt perinatal monitoring systems. In countries like the United States, Meaningful Use standards and Joint Commission recommendations have accelerated software implementation, while similar initiatives are gaining ground across Europe, Asia-Pacific, and Latin America. The global rise in high-risk pregnancies due to lifestyle disorders, assisted reproductive technologies, and delayed maternal age is further driving demand for comprehensive perinatal data management solutions. Moreover, the increasing focus on reducing maternal and neonatal mortality—particularly in developing regions—has led to international funding and public-private partnerships promoting technology adoption. Healthcare workforce shortages, especially in rural and remote settings, are also prompting providers to invest in digital tools that support efficient care delivery and reduce clinical burdens.

What Are the Key Factors Driving the Growth of the Clinical Perinatal Software Market?

The growth in the clinical perinatal software market is driven by several factors directly tied to technology development, end-user needs, and evolving clinical and administrative requirements. The increasing complexity of perinatal care and the need for accurate, real-time clinical decision support are compelling hospitals to adopt advanced digital solutions. Continuous technological improvements—such as AI-integrated monitoring systems, remote fetal surveillance, and interoperability with broader hospital information systems—are enhancing software capabilities and clinical utility. Rising institutional focus on quality metrics, patient safety, and clinical workflow efficiency is also accelerating software implementation. The growing global prevalence of high-risk pregnancies and complications such as gestational diabetes, hypertension, and preterm birth is driving the demand for predictive and proactive perinatal monitoring tools. Additionally, the expansion of maternity care infrastructure in emerging markets and the rising number of births in hospital settings are widening the market base. The increasing adoption of value-based healthcare models, supportive government funding, and growing awareness of digital maternal health solutions are further boosting market penetration. Lastly, the growing emphasis on maternal and neonatal health outcomes as indicators of overall healthcare quality is positioning clinical perinatal software as a strategic investment in both public and private health systems worldwide.

SCOPE OF STUDY:

The report analyzes the Clinical Perinatal Software market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Integrated Clinical Perinatal Software, Standalone Clinical Perinatal Software); Deployment Mode (On-premises Deployment, Cloud-based Deployment); Application (Fetal monitor Data Services Application, Workflow Management Application, Patient Documentation Application); End-Use (Hospitals End-Use, Maternity Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• AS Software LLC
• Ascom Holding AG
• Athenahealth Inc.
• Cerner Corporation
• Clinical Computer Systems Inc. (OBIX)
• Epic Systems Corporation
• GE HealthCare
• Glen Med Solutions
• Hill-Rom Holdings Inc.
• Huntleigh Healthcare Limited
• K2 Medical Systems Ltd
• Koninklijke Philips N.V.
• McKesson Corporation
• MEDITECH (Medical Information Technology)
• PeriGen Inc.
• Revvity
• Sonio SAS
• Stanley Black & Decker, Inc.
• Trium Analysis Online GmbH
• Veradigm Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.